Subscribe To
Artios to present initial phase 1 clinical monotherapy data for atr inhibitor art0380 in advanced solid tumors at the european society of medical oncology congress 2023
ART0380 is a highly competitive, wholly owned ATR inhibitor with broad clinical application alone or in combination for DDR deficient and high replica...
October 5, 2023, 12:00 pm
Why orchard therapeutics stock is soaring today
Orchard Therapeutics, a small-cap gene therapy company, landed a premium-rich buyout offer from Kyowa Kirin today. With biotech valuations under press...
October 5, 2023, 11:37 am
Iris energy steadily advancing 80mw expansion at childress bitcoin mining operation
Iris Energy Limited (NASDAQ:IREN) said in its monthly update that its plan to add another 80MW to its Childress bitcoin mining operation in Texas is c...
October 5, 2023, 9:08 am
Merck blockbuster shows promise in bladder cancer
Merck & Co Inc (NYSE:MRK) has announced promising results from its phase III clinical trial of its bloc...
October 5, 2023, 8:43 am
Okyo pharma phase ii dry eye trial making encouraging progress
OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer, has reported encouraging safety data for its ongoing ...
October 5, 2023, 7:58 am
Oculis to present a late-breaking abstract at the 23rd euretina congress on positive phase 3 stage 1 diamond trial results for diabetic macular edema
ZUG, Switzerland, and BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis” or the “Company”), a global biopharm...
October 5, 2023, 6:30 am
Valneva's vaccination valor: a buy rating justified
Valneva's 1H 2023 revenue declined compared to the previous year, but product sales more than doubled, driven by the recovery in the travel market. Th...
October 4, 2023, 11:45 pm
Gritstone bio announces presentations from phase 1 studies evaluating next-generation vaccine candidate for covid-19 at idweek 2023
EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop t...
October 4, 2023, 8:05 pm
Why nuvalent stock was soaring wednesday
Nuvalent is a clinical-stage biotech. The company said its therapy showed effectiveness and a strong safety profile in its ...
October 4, 2023, 4:13 pm
Veradigm (mdrx) advances tie-up to enhance care delivery
Veradigm's (MDRX) new phase of strategic investment is likely to drive innovation and close the evidenc...
October 4, 2023, 2:16 pm
Moderna ceo on combo covid, flu vaccine moving to next trial phase
A lot of Americans are planning on getting both a flu shot and Covid booster this fall. But Moderna (MRNA) has been working on a combination flu and C...
October 4, 2023, 12:55 pm
Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics
CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...
October 4, 2023, 12:14 pm
Hillcrest energy secures government funding for electric vehicle inverter development program
Hillcrest Energy Technologies Ltd (CSE:HEAT, OTCQB:HLRTF) announced it has received support from the Canadian government through a multi-...
October 4, 2023, 8:56 am
Why is gain therapeutics (ganx) stock moving today?
Gain Therapeutics (NASDAQ: GANX ) stock is on the move Wednesday as investors react to updated clinical trial news from the company. According to a p...
October 4, 2023, 8:45 am
Moderna reports positive results for combination flu and covid vaccine
Moderna Inc. announced positive interim results from a phase 1/2 trial of its combination vaccine again...
October 4, 2023, 8:09 am
Structure therapeutics: tipping the scales in obesity management
Structure Therapeutics' oral small molecule GLP-1, GSBR-1290, has shown promising results in phase 1b s...
October 3, 2023, 11:28 pm
Galan lithium says phase 2 dfs for hombre muerto west delivered irr of 43% and npv of $2b
(Kitco News) - According to the phase 2 DFS results, the HMW project delivers a post-tax NPV8% of US$2 ...
October 3, 2023, 5:52 pm
Tg therapeutics: racing against time while their differentiators are still relevant
TG Therapeutics has transitioned from a developer of oncology drugs to a commercial-stage neurology company with the approval of its multiple sclerosi...
October 3, 2023, 2:26 pm
Novartis (nvs) announces positive data on kidney disease drug
Novartis' (NVS) phase III study on pipeline candidate iptacopan in patients with IgAN shows superiority...
October 3, 2023, 1:32 pm
Aligos therapeutics announces award of an $8.5 million niaid contract to advance development of best-in-class pan-coronavirus protease inhibitor, alg-097558
– NIAID contract will support conducting nonclinical and clinical studies to advance ALG-097558 into future ...
October 3, 2023, 11:30 am